These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Salmeterol xinafoate in asthma. Palmer JB; Oxford JM JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861 [No Abstract] [Full Text] [Related]
9. Salmeterol, inhaled corticosteroids, and tolerance to allergen bronchoprotection. Cockcroft DW; Davis BE; Swystun VA Chest; 1999 Nov; 116(5):1497-8. PubMed ID: 10559129 [No Abstract] [Full Text] [Related]
10. The clinical trials in the initial five-year award period of the Asthma Clinical Research Network. Chinchilli VM; Drazen JM; Fish JE; Lemanske RF; Lazarus SC; Martin RJ; Control Clin Trials; 2001 Dec; 22(6 Suppl):126S-34S. PubMed ID: 11728619 [TBL] [Abstract][Full Text] [Related]
11. Why SMART about second-line treatment when first-line treatment is being ignored? Currie GP Chest; 2006 Sep; 130(3):929; author reply 929. PubMed ID: 16963701 [No Abstract] [Full Text] [Related]
12. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853 [TBL] [Abstract][Full Text] [Related]
18. Cause of death in the SMART Trial. Williams C Chest; 2006 Sep; 130(3):929-30; author reply 930. PubMed ID: 16963700 [No Abstract] [Full Text] [Related]
19. Salmeterol xinafoate vs albuterol in asthma: was race a factor? Olopade CO JAMA; 1994 Nov 23-30; 272(20):1576. PubMed ID: 7966862 [No Abstract] [Full Text] [Related]